These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20002594)

  • 1. An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
    Krymchantowski AV; Jevoux C; Moreira PF
    Pain Med; 2010 Jan; 11(1):48-52. PubMed ID: 20002594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study.
    Krymchantowski AV; Jevoux C
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):615-8. PubMed ID: 18949250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of migraine using flunarizine (results of a pilot study using Amalium)].
    Wessely P; Holzner F
    Wien Med Wochenschr; 1987 Jan; 137(1):21-6. PubMed ID: 3590812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of migraine: Part II. Preventive therapy.
    Noble SL; Moore KL
    Am Fam Physician; 1997 Dec; 56(9):2279-86. PubMed ID: 9402813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunarizine for prophylactic treatment of childhood migraine.
    Visudtibhan A; Lusawat A; Chiemchanya S; Visudhiphan P
    J Med Assoc Thai; 2004 Dec; 87(12):1466-70. PubMed ID: 15822542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol].
    Gracia-Naya M; Huerta-Villanueva M; Rios C; Garcia-Gomara MJ; Artal-Roy J; Sanchez-Valiente S; Santos-Lasaosa S; Mauri-Llerda JA; Latorre-Jimenez AM
    Rev Neurol; 2012 Mar; 54(5):277-83. PubMed ID: 22362476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the duration of migraine prophylaxis.
    Silva-Néto RP; Almeida KJ; Bernardino SN
    J Neurol Sci; 2014 Feb; 337(1-2):38-41. PubMed ID: 24308946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
    Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
    Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine preventive therapy: selection of appropriate patients and general principles of management.
    D'Amico D; Lanteri-Minet M
    Expert Rev Neurother; 2006 Aug; 6(8):1147-57. PubMed ID: 16893343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.
    Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB
    Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive migraine treatment.
    Silberstein SD
    Neurol Clin; 2009 May; 27(2):429-43. PubMed ID: 19289224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial.
    Rossi P; Fiermonte G; Pierelli F
    Funct Neurol; 2003; 18(3):155-9. PubMed ID: 14703897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment.
    Berilgen MS; Bulut S; Gonen M; Tekatas A; Dag E; Mungen B
    Cephalalgia; 2005 Nov; 25(11):1048-53. PubMed ID: 16232156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.
    Sachs G; Chengappa KN; Suppes T; Mullen JA; Brecher M; Devine NA; Sweitzer DE
    Bipolar Disord; 2004 Jun; 6(3):213-23. PubMed ID: 15117400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.